Get the Daily Brief
Latest Biotech News
AI and Generative Models Transform Drug Discovery
Researchers at MIT and collaborators have pioneered the application of generative artificial intelligence to design novel antibiotic molecules capable of targeting drug-resistant pathogens such as...
Breakthrough Imaging Captures Human Embryo Implantation in 3D
Scientists from the Institute for Bioengineering of Catalonia and Dexeus University Hospital have, for the first time ever, recorded human embryo implantation in real time and three-dimensional...
Strategies and Advances in Cancer Immunotherapy
New clinical trials and studies reveal advancements in cancer immunotherapy across multiple tumor types. A Phase II trial showed the combination of nab-paclitaxel and cisplatin outperforming...
Innovations in Neonatal and Pediatric Care
Promising advancements emerged in neonatal and pediatric healthcare. Airway Therapeutics announced an expanded multinational Phase III trial for zelpultide alfa, targeting bronchopulmonary...
Breakthroughs in Materials Science and Energy Storage
Recent innovations in materials science demonstrate significant potential for energy and manufacturing sectors. Researchers unveiled one-dimensional titanate nanotubes designed to enhance...
Regulatory and Funding Developments in Biotech and Healthcare
Notable regulatory and funding developments shape the biotech landscape. The reinstatement of the U.S. childhood vaccine safety task force aims to enhance vaccine monitoring amid controversial...
Emerging Discoveries in Immunology and Cellular Biology
Cutting-edge research deepens understanding of immune mechanisms and cellular dynamics. Studies reveal that genetically engineered regulatory T cells with chimeric antigen receptors can...
Advances in Diagnostic and Analytical Technologies
Innovations in diagnostic technologies enhance precision medicine and research capabilities. Bionano Genomics reported advancements in optical genome mapping software with AI-driven variant...
FDA Grants Full Approval to Precigen's Gene Therapy for Rare Respiratory Disease
The FDA has granted full and expedited approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), targeting adults with recurrent respiratory papillomatosis (RRP), a rare chronic...
Pfizer’s Sickle Cell Drug Candidate Fails Phase III Trial
Pfizer announced the failure of its sickle cell drug candidate, inclacumab, in a pivotal Phase III clinical trial, where it did not demonstrate significant reduction in vaso-occlusive crises...
New CD40 Agonist Antibody Shows Promise in Metastatic Cancer Trial
Rockefeller University researchers have reported encouraging clinical outcomes from a Phase I trial of 2141.V11, an Fc-optimized CD40 agonistic antibody administered intratumorally to metastatic...
Breakthrough Imaging Captures Human Embryo Implantation in Real Time
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have captured, for the first time, high-resolution three-dimensional videos of human embryo...
AI Technologies Accelerate Drug Discovery and RNA Therapeutics Development
Multiple innovations have leveraged artificial intelligence to accelerate drug discovery pipelines and RNA vaccine design. Researchers at MIT utilized generative AI to design novel antibiotic...
Eli Lilly Raises European Drug Prices to Align with US Market
Eli Lilly announced a planned increase in the list prices of its weight-loss drug Mounjaro across Europe, including a 170% hike in the United Kingdom, aligning pricing closer to US levels. This...
Advances in Neonatal Respiratory Care and Drug Trials for Preterm Infants
Clinical research is advancing treatments for bronchopulmonary dysplasia (BPD) in preterm infants. Airway Therapeutics announced expansion of a multinational Phase III trial testing zelpultide...
Breakthroughs in Cancer Metabolism and Immunotherapy Biomarkers
Recent studies have uncovered novel metabolic vulnerabilities and biomarkers pivotal for improving cancer therapy. Research highlights include: the discovery of immune cell exhaustion reversal...
Innovations in Biomanufacturing and Cell Therapy Manufacturing Expansion
Made Scientific celebrated the grand opening of a new 60,000-square-foot GMP facility in Princeton, NJ, designed to support commercial-scale cell therapy manufacturing. The facility integrates...
Regulatory and Industry Landscape: Vaccine Policy and Biopharma Financing Trends
The US Department of Health and Human Services has reinstated the vaccine safety task force nearly three decades after its dissolution, aiming to improve oversight and vaccine safety amidst public...
FDA Accelerates Gene Therapy Approval for Rare Respiratory Disease
The U.S. Food and Drug Administration has granted full and rapid approval to Precigen Inc.’s gene therapy, Papzimeos (zopapogene imadenovec), addressing recurrent respiratory papillomatosis (RRP),...
AI-Powered Antibiotic Discovery Targets Resistant Bacteria
Researchers at MIT have developed a cutting-edge generative artificial intelligence platform to design novel antibiotic molecules effective against highly resistant pathogens including Neisseria...